14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 8th May 2024 ENZC stock ended at $0.0040. This is 15.74% less than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 38.89% from a day low at $0.0036 to a day high of $0.0050.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Enzolytics Inc prices

Date Open High Low Close Volume
May 08, 2024 $0.0041 $0.0050 $0.0036 $0.0040 7 291 683
May 07, 2024 $0.0047 $0.0051 $0.0040 $0.0047 10 061 980
May 06, 2024 $0.0031 $0.0044 $0.0031 $0.0043 21 629 372
May 03, 2024 $0.0043 $0.0047 $0.0031 $0.0035 78 150 955
May 02, 2024 $0.0049 $0.0055 $0.0040 $0.0045 14 761 844
May 01, 2024 $0.0048 $0.0055 $0.0048 $0.0053 7 604 402
Apr 30, 2024 $0.0050 $0.0053 $0.0048 $0.0049 9 016 850
Apr 29, 2024 $0.0052 $0.0053 $0.0042 $0.0051 10 291 195
Apr 26, 2024 $0.0050 $0.0055 $0.0043 $0.0052 34 793 843
Apr 25, 2024 $0.0043 $0.0049 $0.0041 $0.0044 7 202 484
Apr 24, 2024 $0.0042 $0.0055 $0.0036 $0.0043 37 297 480
Apr 23, 2024 $0.0027 $0.0045 $0.0027 $0.0042 25 394 586
Apr 22, 2024 $0.0036 $0.0037 $0.0016 $0.0029 99 284 908
Apr 19, 2024 $0.0045 $0.0054 $0.0045 $0.0048 6 797 371
Apr 18, 2024 $0.0050 $0.0055 $0.0045 $0.0049 10 416 190
Apr 17, 2024 $0.0044 $0.0062 $0.0038 $0.0052 25 882 949
Apr 16, 2024 $0.0059 $0.0060 $0.0042 $0.0044 25 726 007
Apr 15, 2024 $0.0077 $0.0077 $0.0047 $0.0056 77 081 270
Apr 12, 2024 $0.0089 $0.0089 $0.0070 $0.0079 27 423 950
Apr 11, 2024 $0.0090 $0.0090 $0.0083 $0.0086 1 490 174
Apr 10, 2024 $0.0083 $0.0090 $0.0082 $0.0086 3 218 896
Apr 09, 2024 $0.0086 $0.0090 $0.0083 $0.0088 9 433 710
Apr 08, 2024 $0.0087 $0.0088 $0.0082 $0.0085 3 255 125
Apr 05, 2024 $0.0084 $0.0087 $0.0081 $0.0087 5 092 459
Apr 04, 2024 $0.0090 $0.0090 $0.0082 $0.0084 8 030 323
Click to get the best stock tips daily for free!

About Enzolytics Inc

Enzolytics Enzolytics, Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company has clinically tested anti-HIV therapeutics. In addition, it has created a proprietary cell l... ENZC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT